Showing 2251-2260 of 8735 results for "".
Currents: Smart Approaches to Skin Cancer
https://practicaldermatology.com/topics/skin-cancer-photoprotection/currents-smart-approaches-to-skin-cancer/23694/The Dermatology and Aesthetics Market: Continued Mergers and Acquisitions Momentum and Emerging Trends
https://practicaldermatology.com/topics/practice-management/the-dermatology-and-aesthetics-market-continued-mergers-and-acquisitions-momentum-and-emerging-trends/23679/The resilience of the dermatology and aesthetics market, coupled with growth opportunities, continues to fuel the M&A trend.Using Life Insurance for College Planning Strategies
https://practicaldermatology.com/topics/practice-management/using-life-insurance-for-college-planning-strategies/23675/A sometimes-overlooked option can help provide funds for higher education.AI is Transforming Google. What’s it Mean for Your SEO Strategy?
https://practicaldermatology.com/topics/practice-management/ai-is-transforming-google-whats-it-mean-for-your-seo-strategy/23674/Quality content remains important as Google search algorithms become better able to “think” about search queries.Physician Spotlight: George Han, MD, PhD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-george-han-md-phd/23666/Practice Marketing: Top Digital Marketing Trends for 2022
https://practicaldermatology.com/topics/practice-management/practice-marketing-top-digital-marketing-trends-for-2022/23642/Digital marketing can be cost-effective, with many tactics incurring little or no hard costs. Ensure you are truly connecting with current and potential patients.Email Marketing: Why and How To Use It For Your Dermatology Practice
https://practicaldermatology.com/topics/practice-management/email-marketing-why-and-how-to-use-it-for-your-dermatology-practice/23641/Text and social media have not displaced traditional email marketing strategies.DermWireTV: Pfizer, AbbVie JAKs for AD; Spray-on-Skin; Lubriderm Scholarships
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-pfizer-abbvie-jaks-for-ad-spray-on-skin-lubriderm-scholarships/20043/For the treatment of refractory moderate-to-severe atopic dermatitis, FDA has approved Pfizer’s Cibinqo (abrocitinib) for adults and AbbVie’s Rinvoq (upadacitinib) for patients 12 and older. Researchers at the Houston Methodist Research Institute have paired their patented RNA technologies with AvitRethink How You Market Your Practice During the Holidays
https://practicaldermatology.com/topics/practice-management/rethink-how-you-market-your-practice-during-the-holidays/23607/Winter can be the “gift that keeps on giving”—if you know how to leverage the season.Physician Spotlight: Shani Francis, MD, MBA
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-shani-francis-md-mba/23575/